Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (3): 555-559. doi: 10.19723/j.issn.1671-167X.2021.03.019
Previous Articles Next Articles
ZHOU Wu-ping1,MU Nan2,JIAN Wei-yan1,Δ(),WANG Hua-hong3,Δ()
CLC Number:
[1] | 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018,38(9):796-813. |
[2] |
Adamina M, Bonovas S, Raine T, et al. ECCO guidelines on therapeutics in Crohn’s disease: Surgical treatment[J]. J Crohns Colitis, 2020,14(2):155-168.
doi: 10.1093/ecco-jcc/jjz187 pmid: 31742338 |
[3] | 中华医学会消化病学分会炎症性肠病学组, 中华医学会肠外与肠内营养学分会胃肠病与营养协作组. 炎症性肠病营养支持治疗专家共识(第二版)[J]. 中华炎性肠病杂志(中英文), 2018,2(3):154-172. |
[4] |
Lichtenstein GR, Shahabi A, Seabury SA, et al. Lifetime economic burden of Crohn’s disease and ulcerative colitis by age at diagnosis[J]. Clin Gastroenterol Hepatol, 2020,18(4):889-897.
doi: 10.1016/j.cgh.2019.07.022 |
[5] |
Yu Q, Zhu C, Feng S, et al. Economic burden and health care access for patients with inflammatory bowel diseases in China: Web-based survey study[J]. J Med Internet Res, 2021,23(1):e20629.
doi: 10.2196/20629 |
[6] |
Mak WY, Zhao M, Ng SC, et al. The epidemiology of inflammatory bowel disease: East meets west[J]. J Gastroenterol Hepatol, 2020,35(3):380-389.
doi: 10.1111/jgh.v35.3 |
[7] |
Ng SC, Leung WK, Shi HY, et al. Epidemiology of inflammatory bowel disease from 1981 to 2014: Results from a territory-wide population-based registry in Hong Kong[J]. Inflamm Bowel Dis, 2016,22(8):1954-1960.
doi: 10.1097/MIB.0000000000000846 |
[8] |
Pellino G, Keller DS, Sampietro GM, et al. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease[J]. Tech Coloproctol, 2020,24(5):421-448.
doi: 10.1007/s10151-020-02183-z pmid: 32172396 |
[9] |
Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn’s disease: Medical treatment[J]. J Crohns Colitis, 2020,14(1):4-22.
doi: 10.1093/ecco-jcc/jjz180 pmid: 31711158 |
[10] |
Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China[J]. J Dig Dis, 2010,11(2):76-82.
doi: 10.1111/cdd.2010.11.issue-2 |
[11] |
Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: A prospective population-based study in 13 countries or regions in Asia-Pacific[J]. Am J Gastroenterol, 2019,114(1):107-115.
doi: 10.1038/s41395-018-0233-2 |
[12] |
Chen H, Shi J, Pan Y, et al. Cost-effectiveness of reimbursing infliximab for moderate to severe Crohn’s disease in China[J]. Adv Ther, 2020,37(1):431-449.
doi: 10.1007/s12325-019-01150-x |
[13] |
Mao W, Yip CW, Chen W. Complications of diabetes in China: Health system and economic implications[J]. BMC Public Health, 2019,19(1):269. doi: 10.1186/s12889-019-6569-8.
doi: 10.1186/s12889-019-6569-8 |
[14] | 李春燕, 简伟研. 中老年人心血管疾病经济负担——基于中国健康与养老追踪调查的实证分析[J]. 中国卫生政策研究, 2017,10(5):75-80. |
[15] | 袁鸿绯, 郑武, 徐根荣. 台州市区职工医保特殊病门诊支出分析[J]. 中国医疗保险, 2017(10):54-58. |
[16] | 段承阿鑫, 常峰, 路云. 我国各省城镇职工基本医疗保险门诊特殊疾病政策比较研究[J]. 中国卫生事业管理, 2017,34(5):342-345. |
[1] | Qingbo WANG,Hongqiao FU. Main characteristics and historical evolution of China' s health financing transition [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 462-470. |
[2] | ZHOU Yu-Bo, LUO Shu-Sheng, LI Hong-Tian, GAO Yan-Qiu, LIU Jian-Meng. Secular trends of premarital medical examination in China during 1996 and 2013 [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 437-442. |
[3] | LIU Ming, SUN Li-Hua, LIU Guo-恩. Economic burden and economic risk of five major chronic diseases among Chinese urban residents [J]. Journal of Peking University(Health Sciences), 2014, 46(5): 782-789. |
[4] | ZHANG Lei, ZHU Lei, LI Zhi-Heng, LI Jin-Zhou, PAN Hong-Wei, ZHANG Shao-Feng, QIN Wen-Hua, HE Li-Hua. Analysis on the disease burden and its impact factors of coal worker’s pneumoconiosis inpatients [J]. Journal of Peking University(Health Sciences), 2014, 46(2): 226-231. |
|